Wellbiotec Co., Ltd. (KOSE:A010600) announced a private placement of 28th series unregistered non-guaranteed private equity convertible bonds for gross proceeds of KRW 15,000,000,000 on February 25, 2021. The transaction will include participation from Sangsangin Savings Bank, Investment Arm for KRW 10,000,000,000 and returning investor Sangsangin Plus Savings Bank, Investment Arm for KRW 5,000,000,000. The bond is issued at maturity interest rate 2% and surface interest rate 5% and will mature on February 26, 2024. The bonds will be 100% convertible into 5,122,950 common shares of the company at a fixed conversion price of KRW 2,928 per share from February 26, 2022 to January 26, 2024. The board of directors of the company approved the transaction. The subscription and payment date are February 26, 2021.The bonds issued in the transaction will have a hold period of one year from the date of issuance.